Unease grows among U.S. doctors over Indian drug quality

[Reuters] – WASHINGTON/NEW YORK, March 18 (Reuters) – Some U.S. doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration. India su more

View todays social media effects on ACT

View the latest stocks trending across Twitter. Click to view dashboard

See who Actavis is hiring next, click here to view